台股 » 個股 » 東洋 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東洋

(4105)
可現股當沖
  • 股價
    74.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.54%
  • 成交量
    234
  • 產業
    上櫃 生技醫療類股
  • 346人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
東洋 (4105)籌碼相關-元大-蘆洲中正 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-蘆洲中正 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/2400.00375.0073.90-3955-0.31%
2025/04/1500.00272.1072.90-2936-0.21%
2025/04/14170.0000.0070.0019230.11%
2025/04/1000.00172.5071.40-1893-0.11%
2025/04/076.368.507768.5268.20-70.8799-8.85%
2025/04/0200.00275.7075.70-2761-0.26%
2025/03/31373.00172.8072.8027450.27%
2025/03/280.374.00273.7573.80-1.8728-0.24%
2025/03/27474.0800.0074.5047150.56%
2025/03/26778.5400.0078.5076941.01%
2025/03/25178.9000.0078.9016720.15%
2025/03/24279.4000.0079.4026480.31%
2025/03/2100.00179.7079.80-1631-0.16%
2025/03/1900.00979.8679.70-9615-1.46%
2025/03/18579.6000.0080.0056070.82%
2025/03/17679.5300.0079.7066021.00%
2025/03/1300.00279.7579.60-2593-0.34%
2025/03/1200.00180.3080.50-1579-0.17%
2025/03/10080.4000.0080.4005650.00%
2025/03/07080.3000.0080.0005600.00%
2025/03/0600.00280.4580.40-2549-0.36%
2025/03/0400.001680.4780.60-16548-2.92%
2025/03/031080.001.479.4780.008.65241.64%
2025/02/2700.001779.0879.30-17487-3.49%
2025/02/262478.60178.7079.00234774.81%
2025/02/210.476.9000.0076.500.44310.09%
2025/02/1400.00176.7076.60-1432-0.23%
2025/02/13178.2000.0076.9014310.23%
2025/02/11176.4000.0076.2014040.25%
2025/02/0700.001076.6077.00-10400-2.50%
2025/02/0600.00277.5577.40-2394-0.51%
2025/02/040.376.6000.0076.200.33750.07%
2025/01/1500.00174.8074.90-1332-0.30%
2025/01/1400.00174.8075.00-1330-0.30%
2025/01/1000.00374.7775.00-3329-0.91%
2024/12/20172.7000.0072.7013530.28%
2024/12/18272.5000.0073.0023510.57%
2024/12/17372.8300.0072.6033490.86%
2024/12/13173.9000.0073.2013420.29%
2024/11/2900.00175.6075.50-1312-0.32%
2024/11/25174.2000.0074.1012860.35%
2024/11/18073.2000.0072.4002870.00%
2024/11/15572.8000.0072.8052851.75%
2024/11/14173.3000.0073.0012830.35%
2024/11/0100.00273.2573.30-2322-0.62%
2024/10/3000.00173.4073.30-1319-0.31%
2024/10/23173.8000.0073.7013560.28%
2024/09/2700.00174.6074.00-1429-0.23%
2024/09/25173.7000.0073.6014220.24%
2024/09/24074.0000.0073.7004250.00%
2024/09/18273.3500.0073.3024360.46%
2024/09/0500.00173.5073.20-1454-0.22%
2024/09/0400.00173.5073.30-1467-0.21%
2024/08/2900.00174.8074.80-1469-0.21%
2024/08/26474.50474.7074.6004810.00%
2024/08/23274.90174.8074.0014810.21%
2024/08/1200.00173.5073.60-1505-0.20%
2024/08/09173.5000.0073.3015060.20%
2024/08/0700.00172.7072.70-1518-0.19%
2024/08/06370.0000.0071.5035210.58%
2024/08/05672.90171.4070.6055220.96%
2024/07/30773.9900.0073.9075161.36%
2024/07/29274.0000.0074.0025100.39%
2024/07/2300.00075.0075.1004950.00%
2024/07/1800.00376.2076.10-3472-0.64%
2024/07/10776.00176.0075.8064961.21%
2024/07/09176.10176.1076.2004930.00%
2024/07/051276.6200.0076.70124922.44%
2024/07/04776.7900.0076.6074931.42%
2024/07/0100.00176.5076.60-1495-0.20%
2024/06/28176.3000.0076.1014940.20%
2024/06/2400.00076.7076.3005910.00%
2024/06/1800.000.676.5076.90-0.6634-0.09%
2024/06/05577.6000.0077.6057060.71%
2024/05/31276.7500.0077.6027430.27%
2024/05/29177.2000.0077.0017720.13%
2024/05/2800.00277.2077.30-2777-0.26%
2024/05/27277.1500.0077.1027850.25%
2024/05/23277.150.177.6077.001.98010.24%
2024/05/22278.05377.7078.00-1803-0.12%
2024/05/210.178.1000.0078.100.18190.01%
2024/05/14677.701277.7577.80-6843-0.71%
2024/05/09678.27578.0078.0018280.12%
2024/04/29177.0000.0077.3018020.12%
台灣羅氏癌症藥物策略性授權東洋 拓展精準醫療發展Anue鉅亨-8天前
〈熱門股〉東洋海外市場逐步發酵 獲三大法人連續買超按讚Anue鉅亨-21天前
東洋拓展海外市場效益發酵 2024全年EPS達5.83元創高Anue鉅亨-2025/03/26
東洋 相關文章